Akut limfoid leukémia (ALL): vizsgálatok itt: Kanada
30 trials · From ClinicalTrials.gov, checked 2026. november 10.. Ask the study team whether a trial fits you.
- 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Montreal
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - No phaseTaking peoplePediatric Orthopaedic Implant Safety & Efficacy
- Where
- Vancouver
- Életkor
- 0 év to 25 év
- People
- 4000
- Run by
- University of British Columbia
See details and how to joinNCT05361980 - 3. fázisTaking peopleInotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
- Where
- Calgary, Halifax, Montreal, Ottawa, Winnipeg
- Életkor
- 18 év to 39 év
- People
- 303 worldwide
- Run by
- Alliance for Clinical Trials in Oncology
See details and how to joinNCT03150693 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Calgary, Montreal, Toronto
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 2/3. fázisTaking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Toronto
- Életkor
- 12 év and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - 2. fázisTaking peopleA Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Calgary, Edmonton, Halifax, Hamilton, Montreal, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- 366 nap to 46 év
- People
- 222 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06124157 - 1/2. fázisTaking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Montreal, Toronto
- Életkor
- 16 év and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - 1/2. fázisTaking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Toronto, Vancouver
- Életkor
- 12 év and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - 1. fázisTaking peopleCLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies
- Where
- Calgary, Ottawa, Toronto, Vancouver
- Életkor
- 1 év and over
- People
- 24
- Run by
- British Columbia Cancer Agency
See details and how to joinNCT06208735 - 3. fázisTaking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Fredericton, Montreal
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Montreal, Toronto
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Toronto
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 3. fázisTaking peopleStudy of Out of Specification for Tisagenlecleucel
- Where
- Hamilton, Montreal, Ottawa, Québec, Toronto
- Életkor
- 0 év to 100 év
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04094311 - 2/3. fázisTaking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Calgary, Montral, Montreal, Toronto, Vancouver, Winnipeg
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - 2. fázisTaking peopleA Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
- Where
- Calgary, Edmonton, Halifax, Montreal, Québec, Sherbrooke, St. John's, Vancouver, Winnipeg
- Életkor
- 1 év to 30 év
- People
- 461 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04546399 - 3. fázisTaking peopleInotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
- Where
- Calgary, Edmonton, Halifax, Hamilton, Kingston, London, Montreal, Ottawa, Québec, Saskatoon, Sherbrooke, St. John's, Toronto, Vancouver, Winnipeg
- Életkor
- 365 nap to 25 év
- People
- 5951 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT03959085 - 1/2. fázisTaking peopleThe Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Where
- Calgary, Edmonton, Halifax, London, Montreal, Ottawa, Québec, Sherbrooke, Toronto, Vancouver, Winnipeg
- Életkor
- Up to 22 év
- People
- 960 worldwide
- Run by
- PedAL BCU, LLC
See details and how to joinNCT04726241 - No phaseTaking peopleA Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
- Where
- London
- Életkor
- 6 év to 39 év
- People
- 330 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT05702645 - 2. fázisNot yet taking people in KanadaSubcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL
- Where
- Edmonton
- Életkor
- 18 év and over
- People
- 80
- Run by
- University of Alberta
See details and how to joinNCT07301424 - 1/2. fázisTaking peopleTINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Where
- Calgary, Edmonton, Hamilton, Montreal, Québec, Vancouver
- Életkor
- Up to 1 év
- People
- 90 worldwide
- Run by
- Tanja Andrea Gruber
See details and how to joinNCT05848687 - No phaseTaking peopleEffects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Where
- Calgary, Hamilton, Montreal, Ottawa, Québec, Toronto
- People
- 420 worldwide
- Run by
- Children's Oncology Group
See details and how to joinNCT01790152 - 1. fázisNot yet taking people in KanadaPhase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma
- Where
- Montreal, Toronto
- Életkor
- 2 év to 12 év
- People
- 12
- Run by
- Michel Duval
See details and how to joinNCT07518654 - 1/2. fázisTaking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Calgary, Edmonton
- Életkor
- 12 év and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555 - No phaseTaking peopleExercise MRI to Evaluate Cardiorespiratory Fitness in Children With Heart Disease
- Where
- Edmonton
- Életkor
- 10 év to 18 év
- People
- 20
- Run by
- University of Alberta
See details and how to joinNCT06325280 - No phaseTaking peopleHIIT in Pediatric Heart Transplant Recipients (MedBIKE™)
- Where
- Edmonton
- Életkor
- 10 év to 18 év
- People
- 10
- Run by
- University of Alberta
See details and how to joinNCT05451979